Osteoporosis News and Research

Latest Osteoporosis News and Research

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

IOF publishes practical guidelines to help doctors assess patient response to osteoporosis treatment

The International Osteoporosis Foundation (IOF) has published practical guidelines to assist clinicians in assessing treatment efficacy in patients who experience a fracture while on medication for osteoporosis.

1 Sep 2012

Mexican-Americans with ancestral links have higher insulin resistance levels

Mexican-Americans with an ancestral link to Amerindian tribes were found to have higher insulin resistance levels, which is an indication of several chronic conditions such as type 2 diabetes, according to research by The University of Texas Health Science Center at Houston (UTHealth).

26 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

FSH-specific polyclonal antibody might offer more effective way to prevent osteoporosis

A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.

21 Aug 2012

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, is reporting today that a clinical phase Ib trial of the company's candidate drug (CD) MIV-711 has commenced.

21 Aug 2012

Controversial activities of pro-anorexic bloggers may have benefits

A groundbreaking new research study from Indiana University suggests there may be benefits to the controversial activities of "pro-ana" bloggers, the online community for people with eating disorders.

20 Aug 2012

Mepolizumab almost halves exacerbations in severe asthma patients

The largest study of patients with severe asthma to date, published in The Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50% reduction in severe exacerbations, emergency room visits, and hospitalisations compared with patients given placebo.

17 Aug 2012

Intake of Mediterranean diet enriched with olive oil may increase serum osteocalcin concentrations

A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) shows consumption of a Mediterranean diet enriched with olive oil for two years is associated with increased serum osteocalcin concentrations, suggesting a protective effect on bone.

16 Aug 2012

Physical activity effective in reducing sclerostin in premenopausal women

A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that physical activity for premenopausal women is very effective in reducing sclerostin-a known inhibitor of bone formation. In addition, physical training enhances IGF-1levels, which have a very positive effect on bone formation.

16 Aug 2012

Cathepsins may attack one another instead of the bodily proteins

Researchers for the first time have shown that members of a family of enzymes known as cathepsins - which are implicated in many disease processes - may attack one another instead of the bodily proteins they normally degrade. Dubbed "cathepsin cannibalism," the phenomenon may help explain problems with drugs that have been developed to inhibit the effects of these powerful proteases.

15 Aug 2012

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer seems like good medicine.

8 Aug 2012

IOF to hold major osteoporosis meeting from December 13-16 in Malaysia

The International Osteoporosis Foundation will hold its 3rd IOF Regionals - Asia-Pacific Osteoporosis Meeting from December 13 to 16, 2012 in Kuala Lumpur, Malaysia. IOF looks forward to the participation of more than 1000 health professionals from varied fields including orthopaedics, endocrinology, rheumatology, gynaecology, radiology, rehabilitation and general practice.

8 Aug 2012

IOF, PAOS invite medical professionals to attend CME-accredited meeting in Jordan

The International Osteoporosis Foundation (IOF) and the Pan Arab Osteoporosis Society (PAOS) invite medical professionals to attend their joint meeting at the King Hussein Bin Talal Convention Centre, Dead Sea, Jordan, from September 27 to October 1, 2012.

6 Aug 2012

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore Medical Center has launched the nation's first fellowship program in Women's Physical Medicine and Rehabilitation (WPM&R), and established a new clinical program in this specialty.

6 Aug 2012

Alcohol decreases turnover of bone in post-menopausal women

Women after menopause tend to develop weaker bones from what is known as osteoporosis, which may lead to fractures (especially hip fractures) from falling. The weakness of the bones results from an imbalance between the normal resorption (a type of dissolving of old bone) and the laying down of new bone, an ongoing process for both men and women referred to as "bone turnover."

3 Aug 2012

Researchers uncover 9 new genes associated with bone health

Researchers have uncovered 9 new genes associated with bone health. This collaborative study found clues to the cause of bone disorders such as osteoporosis, osteogenesis imperfecta, and high bone density syndromes by investigating the bone mineral content, strength and flexibility.

3 Aug 2012

Training nurse-pharmacist teams to track discrepancies between patients medications at home and in hospital may reduce conflicts

A study of more than 500 patients admitted to, and discharged from, a big-city medical center suggests that nurse-pharmacist teams trained to track down discrepancies between lists of drugs patients are taking at home and those they are scheduled to take in the hospital might substantially reduce such potentially harmful conflicts.

1 Aug 2012

$Older Medicare patients have reduced risk of hip fracture following cataract surgery$

Older Medicare patients have reduced risk of hip fracture following cataract surgery

Medicare patients 65 years and older who underwent cataract surgery had a lower odds of hip fracture 1 year after the procedure when compared with patients with cataract who did not have cataract surgery, according to a study in the August 1 issue of JAMA.

1 Aug 2012

Array BioPharma announces positive results from ARRY-797 Phase 2 trial on osteoarthritis

Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).

31 Jul 2012

Osteoporosis News and Research

Latest Osteoporosis News and Research

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

IOF publishes practical guidelines to help doctors assess patient response to osteoporosis treatment

Mexican-Americans with ancestral links have higher insulin resistance levels

FDA warns consumers about potential health risks of two natural dietary supplements

FSH-specific polyclonal antibody might offer more effective way to prevent osteoporosis

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Controversial activities of pro-anorexic bloggers may have benefits

Mepolizumab almost halves exacerbations in severe asthma patients

Intake of Mediterranean diet enriched with olive oil may increase serum osteocalcin concentrations

Physical activity effective in reducing sclerostin in premenopausal women

Cathepsins may attack one another instead of the bodily proteins

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

IOF to hold major osteoporosis meeting from December 13-16 in Malaysia

IOF, PAOS invite medical professionals to attend CME-accredited meeting in Jordan

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Alcohol decreases turnover of bone in post-menopausal women

Researchers uncover 9 new genes associated with bone health

Training nurse-pharmacist teams to track discrepancies between patients medications at home and in hospital may reduce conflicts

Older Medicare patients have reduced risk of hip fracture following cataract surgery

Array BioPharma announces positive results from ARRY-797 Phase 2 trial on osteoarthritis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Osteoporosis News and Research

Latest Osteoporosis News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in